Annual Report And Consolidated Financial Statements

Overview

The report describes Immunocore's continued expansion of KIMMTRAK, which was approved in 39 countries and commercially launched in 24 countries by December 2024. It reports total group revenue of £242,081 thousand for 2024. The report also discloses 2,589.66 tonnes of estimated greenhouse gas emissions and energy consumption of more than 40,000 MWh, supported by energy-efficiency initiatives across UK facilities.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 27 March 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services